U.S. Nurses Believe They Considerably Influence Patient Health Decisions and Behavior

Manhattan ResearchAccording to pharmaceutical and healthcare market research company Manhattan Research, U.S. nurses believe they considerably influence patients' health decisions and behavior. The Taking the Pulse® Nurses v10.0 study found that the majority of online nurses report that they influence how their patients follow through with their treatment regimens. The study also found that most online nurses encourage patients to take advantage of health and condition websites and are significantly more likely than physicians to recommend these resources to their patients. The research is based on interviews with over 1,000 U.S. nurses and physician assistants (PAs) and focuses on the media and device preferences, professional resource mix, and digital behaviors and attitudes of these segments.

"Marketers shouldn't underestimate the influence nurses have on how patients think about medication and follow their treatment plan. This new nursing study, as well as past consumer studies, unequivocally show that nurses play a pivotal role in this regard," said Monique Levy, Senior Director of Research at Manhattan Research. "We've seen several brands and marketers already jump on this opportunity - especially given the flux in physician-directed promotion these days."

About Taking the Pulse® Nurses
The Taking the Pulse® Nurses study was conducted in Q2 2010 among 1,023 U.S. practicing nurses and physician assistants (PAs) via online survey methodology. Key topics include technology and Internet use for professional purposes; resources like medical references, journals, and conferences; email use and opportunity; patient interaction and educational sources; handheld devices and mobile activities; practice technology such as electronic prescribing and EMR; continuing education; and digital interaction with pharma companies, including product and corporate websites and HCP service portals.

Healthcare and pharmaceutical marketers and other industry stakeholders use Taking the Pulse® Nurses to examine technology, media, channel, and promotional mix strategies, as well as to benchmark their performance against industry competitors. In addition to analyzing overall market trends, clients will be able to segment the study to derive statistically relevant insights across over twenty specialist groups.

For additional product and subscription information, please visit:
http://www.manhattanresearch.com/ttpnurses

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Nurses, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health®, Cybercitizen Health® Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis for over 100 consumer therapeutic segments and physician specialist segments. For more information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Regorafenib to be tested in brain cancer patients …

Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in the US ...

Sanofi and Google to develop new healthcare Innova…

Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping i...

Bristol-Myers Squibb provides update on pending me…

Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation (NASDAQ: ...

Japan becomes the first country to approve Roche's…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of a...

Breztri Aerosphere (PT010) approved in Japan for p…

AstraZeneca announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy...

FDA approves Amgen and Allergan's KANJINTITM (tras…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTITM (trastuzumab-anns) for all approved ind...

Vitamin D may not help your heart

While previous research has suggested a link between low levels of vitamin D in the blood and an increased risk of cardiovascular disease, a new Michigan State University...

Human-on-a-chip model tests cancer drug efficacy a…

A reconfigurable "body-on-a-chip" model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organ...

Pathogen engineered to self-destruct underlies can…

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-dest...

Artificial DNA can control release of active ingre…

A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was o...

How gastric stem cells fight bacteria

Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by re...

Researchers identify enzyme that suppresses immune…

Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing. In breast cancer especially, only a ...